In addition, we found that the gene expression levels of MS4A1 and MS4A2 [40] were significantly higher in tumor tissues compared to normal tissues (Fig. S1D) and LUAD patients with higher expression levels exhibited better prognostic [41] based on existing IHC studies and experimental data, which is consistent with the above studies. The gene discussed is MS4A1; the disease is neoplasm.